← brief for 2026-08-13 · Slowing decline

Safety and Tolerability of SGLT2 Inhibitors.

Article A Peer reviewed Meta-analysis or large trial

Key takeaways

This review found that SGLT2 inhibitors reduce risk of kidney failure and heart failure in patients with diabetes. It also covers risks like urinary tract infections and ketoacidosis. No new results in this batch.

Who did this work

Muskiet MHA · van Raalte DH · Smits MM

Source

Article · PubMed, the drug frontier · 2026 Aug 13
https://pubmed.ncbi.nlm.nih.gov/42587086/